These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11166147)

  • 1. Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
    Sakashita M; Aoyama N; Minami R; Maekawa S; Kuroda K; Shirasaka D; Ichihara T; Kuroda Y; Maeda S; Kasuga M
    Eur J Cancer; 2001 Jan; 37(2):204-9. PubMed ID: 11166147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
    Haber RS; Rathan A; Weiser KR; Pritsker A; Itzkowitz SH; Bodian C; Slater G; Weiss A; Burstein DE
    Cancer; 1998 Jul; 83(1):34-40. PubMed ID: 9655290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.
    Kawamura T; Kusakabe T; Sugino T; Watanabe K; Fukuda T; Nashimoto A; Honma K; Suzuki T
    Cancer; 2001 Aug; 92(3):634-41. PubMed ID: 11505409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in MT expression in early-stage depressed-type and polypoid-type colorectal tumours.
    Kuroda K; Aoyama N; Tamura T; Sakashita M; Maekawa S; Inoue T; Wambura C; Shirasaka D; Minami R; Maeda S; Kuroda Y; Kasuga M
    Eur J Cancer; 2002 Sep; 38(14):1879-87. PubMed ID: 12204670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
    Younes M; Lechago LV; Lechago J
    Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes.
    Ravazoula P; Batistatou A; Aletra C; Ladopoulos J; Kourounis G; Tzigounis B
    Eur J Gynaecol Oncol; 2003; 24(6):544-6. PubMed ID: 14658600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
    Chung JH; Cho KJ; Lee SS; Baek HJ; Park JH; Cheon GJ; Choi CW; Lim SM
    J Nucl Med; 2004 Jun; 45(6):999-1003. PubMed ID: 15181136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival.
    Younes M; Brown RW; Stephenson M; Gondo M; Cagle PT
    Cancer; 1997 Sep; 80(6):1046-51. PubMed ID: 9305704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer.
    Rudlowski C; Moser M; Becker AJ; Rath W; Buttner R; Schroder W; Schurmann A
    Oncology; 2004; 66(5):404-10. PubMed ID: 15331928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
    Zhou YL; Deng CS
    Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
    Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES
    Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of glucose transporter 1 (
    Vasudevan S; Mehta A; Sharma SK; Sharma A
    J Cancer Res Ther; 2022; 18(3):650-655. PubMed ID: 35900536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis].
    Wei B; Chen L; Li J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):277-80. PubMed ID: 19434538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
    Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
    Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
    Kim YW; Park YK; Yoon TY; Lee SM
    Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
    Younes M; Juarez D; Lechago LV; Lerner SP
    Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
    Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y
    Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.
    Kang SS; Chun YK; Hur MH; Lee HK; Kim YJ; Hong SR; Lee JH; Lee SG; Park YK
    Jpn J Cancer Res; 2002 Oct; 93(10):1123-8. PubMed ID: 12417042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence.
    Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Baba Y; Sugihara H; Izumi D; Kurashige J; Baba H
    Ann Surg Oncol; 2014 May; 21(5):1756-62. PubMed ID: 24242681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.